Anavex Life Sciences Corp. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AVXL Nasdaq 2836 www.anavex.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anavex Life Sciences Corp.

High Growth Tech Stocks To Watch In The US June 2025 - Jun 16th, 2025 11:38 am
We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn - Jun 13th, 2025 6:54 am
Anavex Life Sciences Corp.'s (NASDAQ:AVXL) largest shareholders are individual investors with 60% ownership, institutions own 37% - May 17th, 2025 6:24 am
Anavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlights: Promising Alzheimer's Data ... - May 14th, 2025 3:01 pm
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences - May 14th, 2025 5:30 am
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - May 13th, 2025 5:37 am
Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update - May 13th, 2025 5:30 am
Is Anavex Life Sciences Corp. (AVXL) the Low Risk High Reward Stock Set to Triple by 2030? - May 9th, 2025 6:25 am
Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025 - May 6th, 2025 5:30 am
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia - May 1st, 2025 5:30 am
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference - Apr 30th, 2025 5:30 am
Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board - Apr 23rd, 2025 5:30 am
Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ... - Apr 21st, 2025 2:41 pm
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East - Apr 21st, 2025 5:30 am
High Growth Tech Stocks To Watch In The US Market - Apr 7th, 2025 11:08 am
AD/PD 2025: Long-term data shows Anavex’s Blarcamesine benefits in early Alzheimer’s - Apr 7th, 2025 10:49 am
Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years - Apr 7th, 2025 10:10 am
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease - Apr 5th, 2025 9:30 am
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference - Mar 31st, 2025 5:30 am
Exploring 3 High Growth Tech Stocks In The US Market - Mar 7th, 2025 4:08 am